<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02880111</url>
  </required_header>
  <id_info>
    <org_study_id>2012_44</org_study_id>
    <secondary_id>2014-A00259-38</secondary_id>
    <secondary_id>PHRCI-2012</secondary_id>
    <nct_id>NCT02880111</nct_id>
  </id_info>
  <brief_title>Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients With Pseudomonas Aeruginosa</brief_title>
  <acronym>DMBT1</acronym>
  <official_title>Comparison of Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients Colonized Patients Between Chronic and Non-chronic Patients Colonized With Pseudomonas Aeruginosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rates of DMBT1 (Glycoprotein like) in Sputum of CF Patients with or without may be different
      according to their Pseudomonas Aeruginosa chronic colonization status. The aim of this study
      is to compare rates of DMBT1 (Glycoprotein like) in Sputum of CF patients with or without a
      Pseudomonas Aeruginosa chronic colonization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rates of DMBT1 (Deleted in Malignant Brain Tumor 1) will be compared between 2 groups of 30
      CF patients : group 1 : with Pseudomonas Aeruginosa chronic colonization and group 2 30 CF
      patients without Pseudomonas Aeruginosa chronic colonization.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measure glycoprotein-like DMBT1 by Elisa</measure>
    <time_frame>at 1 months</time_frame>
    <description>DMBT1 in mg DMBT1 / mg of total protein measured by BCA (BiCinchoninic acid Assay) present in each sputum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>measure MUC5B by Elisa</measure>
    <time_frame>at 1 months</time_frame>
    <description>MUCB in mg / mg of total protein measured by BCA present in each sputum</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Malignant Brain Tumor</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <description>CF patients with Pseudomonas aeruginosa chronic colonization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <description>CF patients without a Pseudomonas aeruginosa chronic colonization.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        CF Patients with or without Pseudomonas aeruginosa chronic colonization status aged 6 to 35
        years.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CF patient 6 to 35 years

          -  Availability of sputum

          -  Signed Informed consent

        Exclusion Criteria:

          -  Cardiac insufficiency

          -  Anti-inflammatory drugs on going

          -  Oral corticosteroid therapy

          -  Inhaled corticosteroids during the two weeks before inclusion,

          -  Patient awaiting lung transplantation

          -  Patient with a past history of heart/lung transplantation

          -  Patient with a sputum examination positive for : atypical mycobacteria, Burkholderia
             cepacia, Stenotrophomonas maltophilia,

          -  Patient chronically colonized with multiresistant Pseudomonas aeruginosa

          -  Inhaled Colymicine® or Tobramycin® during the two weeks before inclusion

          -  Change of the CF treatment during the last 4 weeks +/- 2 days before inclusion :
             corticosteroid, pancreatic extracts, antisecretory drugs...
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Turck, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominique Turck, MD,PhD</last_name>
    <email>dominique.turck@chru-lille.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurent BEGHIN, PhD</last_name>
    <email>laurent.beghin@chru-lille.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Jeanne de Flandre - CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dominique TURCK, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2016</study_first_submitted>
  <study_first_submitted_qc>August 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2016</study_first_posted>
  <last_update_submitted>February 16, 2018</last_update_submitted>
  <last_update_submitted_qc>February 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Malignant Brain Tumor</keyword>
  <keyword>patient sputum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
    <mesh_term>Pseudomonas Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Krestin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

